Natus Launches autoSCORE AI Tool to Transform EEG Analysis

Natus Medical Incorporated has announced the global launch of its innovative autoSCORE analysis tool, a significant advancement in the field of neurodiagnostics. This tool, which employs a deep-learning model developed in Norway by Holberg EEG, is designed to enhance the efficiency and accuracy of electroencephalogram (EEG) analyses.

The autoSCORE tool was first introduced to the United States market in August 2024 for routine EEG studies. This rollout made U.S. neuro care teams the first to utilize its capabilities, which aim to alleviate the burden on clinical resources and staff. The tool has been trained on 30,000 expertly labeled EEG recordings and is exclusively offered with Natus NeuroWorks software. It has received FDA 510(k) clearance for expanded indications, including routine EEG, long-term monitoring (LTM), and ambulatory EEG studies, and has also received the CE mark for distribution in Europe and other international markets.

“Developing the first AI model capable of interpreting clinical EEGs at the level of the world’s top experts marks a defining moment for both Natus and the field of neurodiagnostics,” stated Chris Landon, CEO of Natus Neuro. “Now, we’re proud to bring this breakthrough innovation to healthcare providers globally – advancing our mission to expand patient access and deliver life-changing outcomes through cutting-edge neuro solutions.”

The introduction of autoSCORE has been welcomed by early adopters, who appreciate its ability to assess not only traditional spike and seizure detections but also multiple clinically relevant abnormalities. This tool provides study-level assessments, helping healthcare providers determine whether an EEG study is normal or abnormal. The closed AI model ensures consistency and security, further enhancing its reliability.

“Human teaming with intelligent machines has become a fundamental characteristic of a successful clinical decision support system,” said Dr. Ram Mohan Sankaraneni, a board-certified neurologist and fellow of the American Epilepsy Society and the American Academy of Neurology. “autoSCORE is a reliable colleague that can provide a second opinion… a powerful pathway to faster interventions.”

Visual EEG review remains the gold standard for identifying abnormalities, yet it often places a strain on department resources. The AI-enabled autoSCORE application is designed to optimize the efficiency and consistency of EEG data analysis, allowing clinical teams to focus more on patient care.

Natus is recognized globally as a trusted provider of solutions for screening, diagnosing, and treating disorders affecting the brain and neural pathways. Its best-in-class products and services, including comprehensive field support and education, enable clinicians to enhance their standard of care, ultimately improving patient outcomes and quality of life.

For further information about Natus and its offerings, visit natus.com/neuro.

For media inquiries, please contact:
Lisa Schuler
Phone: +1 612 528-1332
Email: [email protected]

The launch of autoSCORE represents a pivotal moment in the integration of artificial intelligence within clinical settings, promising to enhance the quality of neurodiagnostic services worldwide.